Will there still be a role for ribavirin and pegylated interferon-alfa?
by Traci Bratton
MedPage Today invited specialists from leading medical institutions to weigh in on the latest advancements in hepatitis C with one question each day for 10 days. Hear what E. Turner Overton, MD, associate professor of medicine, University of Alabama at Birmingham, had to say.